Patent ID: 8969355
Filing Date: 2015-03-03
Classification: A61K,A61P,C07D,Y10T

Abstract:
1. A method of treating a disease selected from the group consisting of affective disorders, depression, major depressive disorder, anxiety, general anxiety disorder, social anxiety disorder, obsessive compulsive disorder, panic disorder, and panic attacks, the method comprising administering a therapeutically effective amount of a pharmaceutically acceptable salt of Compound I to a patient in need thereof, wherein the salt of Compound I is crystalline 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl]piperazine hydrobromide salt characterized by XRPD reflections at 6.89, 9.73, 13.78 and 14.64+/−0.10° 2θ.